Cresilon
Brooklyn
About Cresilon
Cresilon is a medical device company that produces and markets solutions for trauma care. The company’s proprietary product, VETIGEL, is a hemostatic gel made from plant-derived materials to stop traumatic bleeding in seconds. It functions as a blood-clotting agent, and also as a scaffold to facilitate skin growth. Cresilon was co-founded by Joe Landolina and Isaac Miller in 2010 and is based in New York, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $100.7M
- Last round: Series Unknown (Sep 2025)
- Website: cresilon.com
- Phone: +1 (347) 435-2226
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cresilon-104629 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.